Trump’s new policies could impact pharmaceutical costs, focusing on India’s role as a major supplier.
President Donald Trump, after previously sparing the pharmaceutical sector in his trade disputes, is now reconsidering his stance. On April 8, he revealed intentions to implement a significant tariff on […]
Continue Reading